Xenografted colorectal cancer cells overexpressing B7-H3 were more resistant to oxaliplatin while treatment with 2-Deoxy-D-glucose (2-DG), an HK2 inhibitor, reduced tumor size and tumor regrowth rate. This evidence concerns the gene HK2 and colorectal cancer.